fbpx

MedTech

Intelligent health association logo

Innovation within the pharmaceutical field

The Mission of the Medicines Authority is to protect and enhance public health through the regulation of medicinal products and pharmaceutical activities. In today’s world the scope of regulation is increasing to new medicinal products including medical cannabis but also to digital health and tech products which are featuring more commonly as part of medical devices the patient’s healthcare pathway.

Through Med-In Pharma we want to make sure that every stakeholder involved is up-to-date with the latest guidelines and trends in medical cannabis as well as the medical device regulation. This ensures best practice and fosters dialogue to ensure innovation can happen in a secure manner that safeguards the public.

Members of the scientific community practicing in the field of medicine, surgery, dentistry, pharmacy and applied sciences are invited to prepare abstracts related to innovative techniques in medicine, surgery and dentistry enabling technologies, smart factory and future trends in pharmacy and applied sciences for submission to the scientific committee of the Med-In Pharma 2022 Conference. Abstracts which have been accepted by the scientific committee may be presented as a poster.

Authors will be notified on the final results of the review process by 21 October 2022. Accepted abstracts must be presented by one of the authors who must be registered for the Malta Med-Tech World Summit 2022.

Partners

Over the years we have built the Malta Medicines Authority as one of the leading regulatory bodies in Europe. We recently have re-affirmed this through regulation of medical cannabis products and looking to increase our presence in the medical device industry. I believe that through conferences such as this, we can increase awareness about what is happening in the industry and can showcase why Malta is becoming a powerhouse in regulation. I also think that a scientific component through the presentation of research is essential, and that is why a scientific poster presentation will feature in Med-In Pharma to allow researches to show their work in an international forum to stimulate innovation.


Thursday 17th November 2022 (Amphitheater)

10:00-10:10

Introduction to Med-Cann World

Dr Dylan Attard
10:13-10:33

Access to Medicinal Cannabis in Europe. The barriers, challenges and solutions.

MATTHEW LAWSON, STEPHEN OLIVER (Canna Consultants)
10:36-11:06

Cannabinoids in epilepsy: friend or foe?

GIUSEPPE DI GIOVANNI
11:09-11:56

Challenges for the Medical Cannabis Industry in Europe

12:00-12:45

Developing a cannabinoid-based formulation for the treatment of cancer

Prof. Hinanit Koltai, PhD

Friday 18th November 2022 (Amphitheater)

13:00-13:45

Medical Cannabis at the intersection of biotech, pharma and big data - Building a winning portfolio in the emerging medical cannabis field

LILAC MANDELES
13:48-14:03

Export and Import through the European Union. 

14:05-14:50

Christopher Tasker; Master of Cannabinoid Research 

Chris Tasker
14:53-15:33

The Patient’s Choice: Private, Publicly Funded or Self Medication. 

MATTHEW LAWSON, STEPHEN OLIVER, Chris Tasker, MARK GLEDHILL, Kyle Esplin
16:08-16:23

Bioburden: Key considerations for the cannabis industry

Dr. Noelia Holgado Sánchez

speakers

KYLE ESPLIN

PROF. HINANIT KOLTAI
PhD

JACKY ONG

ASSOC. PROF .DR. THAVATCHAI KAMOLTHAM

DR. NOELIA HOLGADO SáNCHEZ

CHRIS TASKER

ALEXANDR FLOKA

YONA CYMERMAN

CHRISTOPHER MORRIS

STEPHAN GATH

LILAC MANDELES

MAX KANEVSKIY

GOLAN BITTON

DR AIMON KOPERA

MARION ZAMMIT

CHRISTIAN DUCHOW

THOMAS GRIMA

RICHARD SANDERS

DR SANDRA CARRILLO

GIUSEPPE DI GIOVANNI

MARK GLEDHILL

MATTHEW LAWSON

STEPHEN OLIVER

DR ANDREW AGIUS

ALEX AGIUS SALIBA

HON. DEO DEBATTISTA

PORNPRASIT SIBUNRUANG

ALEX LATYSHEV

Companies who trusted us